HBI Deals+Insights / News
Global dialysis operators Diaverum and Davita have renewed their contracts with the Saudi Ministry of Health for another five years. The deal leaves Diaverum free to proceed with its plans to IPO / go forward to a private sale and comes in the same week as a new portable dialysis device had its US market entry fast-tracked by the FDA. Is it a threat?